| # | Drug | Count |
|---|---|---|
| 0 | TEDUGLUTIDE | 43 |
| 1 | CYCLOPHOSPHAMIDE | 35 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 35 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 35 |
| 4 | PREDNISONE | 34 |
| 5 | TACROLIMUS | 30 |
| 6 | CYTARABINE | 29 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 29 |
| 8 | TACROLIMUS OINTMENT 0.1% | 29 |
| 9 | MYCOPHENOLATE MOFETIL | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SARGRAMOSTIM | 17 | 0.0098 |
| 1 | TREOSULFAN | 12 | 0.0043 |
| 2 | TEDUGLUTIDE | 43 | 0.0032 |
| 3 | INOTUZUMAB OZOGAMICIN | 7 | 0.0023 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 19 | 0.0023 |
| 5 | THIOTEPA | 12 | 0.0012 |
| 6 | ATOVAQUONE | 10 | 0.0012 |
| 7 | DAPTOMYCIN | 10 | 0.0011 |
| 8 | BUSULFAN | 14 | 0.0009 |
| 9 | BLINATUMOMAB | 9 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 81 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 45 |
| 2 | GLP-2 Analog [EPC] | 43 |
| 3 | Alkylating Drug [EPC] | 37 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 36 |
| 5 | Proton Pump Inhibitor [EPC] | 25 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 7 | Leukocyte Growth Factor [EPC] | 24 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 20 |
| 9 | Glycopeptide Antibacterial [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 43 | 0.0032 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 3 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |
| 4 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 5 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 6 | Lipopeptide Antibacterial [EPC] | 10 | 0.0011 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 8 | Antimalarial [EPC] | 10 | 0.0010 |
| 9 | Antiprotozoal [EPC] | 10 | 0.0009 |